James B. Kahn
Impact in
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
- Epidemiology 33
- Pneumonia and Respiratory Infections 22
- Urinary Tract Infections Management 9
- Pneumocystis jirovecii pneumonia detection and treatment 5
- Pharmacology 28
- Antibiotics Pharmacokinetics and Efficacy 26
- Co-authors
- Clyde Thornsberry (5 shared papers)Yolanda Mauriz (5 shared papers)George L. Drusano (8 shared papers)Alan M. Tennenberg (9 shared papers)Daniel F. Sahm (4 shared papers)Barbara A. Wiesinger (9 shared papers)Jim Xiang (8 shared papers)Mohammed Khashab (7 shared papers)
- Journals
- Journal of Pharmacology and Experimental Therapeutics (7 papers)Antimicrobial Agents and Chemotherapy (7 papers)Current Medical Research and Opinion (6 papers)Clinical Infectious Diseases (5 papers)Clinical Therapeutics (4 papers)
- Partner nations
- United StatesBelgiumNetherlands
In The Last Decade
James B. Kahn
58 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 122
- Molecular Medicine 1.1k
- Applied Microbiology and Biotechnology 420
- Pharmacology 1.4k
- Epidemiology 1.9k
- Clinical Biochemistry 290
Countries citing papers authored by James B. Kahn
This map shows the geographic impact of James B. Kahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James B. Kahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James B. Kahn more than expected).
Fields of papers citing papers by James B. Kahn
This network shows the impact of papers produced by James B. Kahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James B. Kahn. The network helps show where James B. Kahn may publish in the future.
Co-authors
The 25 scholars most cited alongside James B. Kahn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 261 | |
| 2 | 2003 | 250 | |
| 3 | 1997 | 247 | |
| 4 | 2003 | 201 | |
| 5 | 2004 | 197 | |
| 6 | 2003 | 196 | |
| 7 | 2008 | 133 | |
| 8 | 2001 | 106 | |
| 9 | 2003 | 92 | |
| 10 | 2003 | 89 | |
| 11 | 2000 | 78 | |
| 12 | 2002 | 74 | |
| 13 | 2001 | 73 | |
| 14 | 2004 | 68 | |
| 15 | 2009 | 68 | |
| 16 | 2007 | 67 | |
| 17 | 2007 | 60 | |
| 18 | 1996 | 54 | |
| 19 | 2004 | 45 | |
| 20 | 2001 | 42 |
About James B. Kahn
James B. Kahn is a scholar working on Epidemiology, Pharmacology, Molecular Medicine, Clinical Biochemistry and Public Health, Environmental and Occupational Health, having authored 61 papers that have together received 3.0k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (26 papers), Pneumonia and Respiratory Infections (22 papers), Antibiotic Resistance in Bacteria (15 papers), Urinary Tract Infections Management (9 papers), Bacterial Identification and Susceptibility Testing (7 papers), Urinary Bladder and Prostate Research (6 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers) and Reproductive Health and Contraception (4 papers). The work is most often cited by research in Molecular Medicine (1.1k citations), Applied Microbiology and Biotechnology (420 citations), Pharmacology (1.4k citations), Epidemiology (1.9k citations) and Clinical Biochemistry (290 citations). James B. Kahn has collaborated with scholars based in United States, Belgium and Netherlands. Frequent co-authors include Clyde Thornsberry, Yolanda Mauriz, George L. Drusano, Alan M. Tennenberg, Daniel F. Sahm, Barbara A. Wiesinger, Jim Xiang, Mohammed Khashab, Mark E. Jones and Mohammed M. Khashab. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Antimicrobial Agents and Chemotherapy, Current Medical Research and Opinion, Clinical Infectious Diseases and Clinical Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.